J 2023

The Endocannabinoid System - The Prediction of Spontaneous Preterm Birth in High-Risk Women: Protocol of a Study

PARIZEK, Antonin, Martin HILL, Michaela DUSKOVA, Lucie KOLATOROVA, Josef SUCHOPAR et. al.

Basic information

Original name

The Endocannabinoid System - The Prediction of Spontaneous Preterm Birth in High-Risk Women: Protocol of a Study

Authors

PARIZEK, Antonin (203 Czech Republic), Martin HILL (203 Czech Republic), Michaela DUSKOVA (203 Czech Republic), Lucie KOLATOROVA (203 Czech Republic), Josef SUCHOPAR (203 Czech Republic), Patrik SIMJAK (203 Czech Republic), Katerina ANDERLOVA (203 Czech Republic), Eva KUDOVA (203 Czech Republic), Vladimir ROGALEWICZ (203 Czech Republic), Jaroslav VACEK (203 Czech Republic), Marcela KOUDELKOVÁ (203 Czech Republic, belonging to the institution), Renata CHLOUPKOVÁ (203 Czech Republic, belonging to the institution), Miroslava ALBLOVA (203 Czech Republic), Petra PARIZKOVA (203 Czech Republic), Zdenek LASTUVKA (203 Czech Republic) and Miroslav BARTAK (203 Czech Republic, guarantor)

Edition

Physiological research, Praha, Institute of Physiology of the Czechoslovak Academy of Sciences, 2023, 0862-8408

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30105 Physiology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.100 in 2022

RIV identification code

RIV/00216224:14110/23:00133344

Organization unit

Faculty of Medicine

UT WoS

001127421100002

Keywords in English

Anandamide (AEA); Endocannabinoids; Endocannabinoid system; 2-arachidonoylglycerol (2-AG); 2-linoleoylglycerol (2-LG); 2-oleoylglycerol (2-OG); 2-arachidonoyldopamine (2-ADOPA center dot NADA); Predicting preterm birth; Spontaneous preterm birth (sPTB)

Tags

Změněno: 21/3/2024 14:44, Mgr. Tereza Miškechová

Abstract

V originále

Spontaneous preterm birth (sPTB) is a major cause of perinatal morbidity and mortality, even in developed countries. Prediction of sPTB is therefore a valuable tool to reduce the associated risks. The current standard for the prediction of sPTB consists, in addition to anamnestic data, of previous sPTB and previous second trimester miscarriage, measurement of cervical length by transvaginal ultrasound (TVU CL) together with assessment of fetal fibronectin levels in cervicovaginal fluid. Other evaluation parameters, such as the level of endocannabinoids in the pregnant woman's blood, could increase the sensitivity of this management. Endocannabinoids (eCBs) are a part of the endocannabinoid system (ECS); out of them anandamide (arachidonoyl-ethanolamide, AEA), in particular, plays an important role in the regulation of pregnancy and childbirth. We present the protocol for an open, non-randomized study to evaluate concentrations of AEA and other endocannabinoids: 2-linoleoylglycerol (2-AG), 2-linoleoylglycerol (2-LG), 2-oleoylgly-cerol (2-OG), and 2-arachidonoyldopamine (2-ADOPA or also NADA) in the blood of pregnant women as potential predictors of sPTB. In a total of 230 women with a history of sPTB or miscarriage, eCBs levels between 22 and 28 weeks of gestation will be assessed from maternal blood, in addition to the standard procedure. The aim of the study is to determine the relationship between blood concentrations of the endocanna-binoids tested and the risk of sPTB. The results of this study will describe the prognostic significance of maternal blood eCBs levels for sPTB, and could subsequently enable improved screening programs for early identification of sPTB.